Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04147897 · ClinicalTrials.gov registry record · NA
Implementing mHealth for Schizophrenia in Community Mental Health Settings
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 299
- Enrollment target
NCT04147897: Completed NA study, sponsored by University of Washington.
NCT04147897 is a NA study that has completed, run by University of Washington. The registered enrollment target is 299 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04147897, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 299 participants
- Enrollment target
Study Summary
Randomized control trial examining two mHealth intervention strategies.
Primary Outcome
The Patient Health Questionnaire (PHQ)-9 is the major depressive disorder (MDD) module of the full PHQ. Total scores range from 0-27. Higher scores represent more severe symptoms.
Interventions
- DEVICE FOCUS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2020-06-16 |
| Est. Completion | 2024-09-16 |
| Phase | NA |
What the finished NCT04147897 record still lists
NCT04147897 is an interventional study that assigns participants to a tested intervention. The registered 299 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which FOCUS is the first listed.
NCT04147897 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04147897 about?
NCT04147897 is a clinical study titled "Implementing mHealth for Schizophrenia in Community Mental Health Settings". Randomized control trial examining two mHealth intervention strategies.
What is the current status of trial NCT04147897?
This trial is currently completed. It is a NA study. The enrollment target is 299 participants. The study started on 2020-06-16. Estimated completion is 2024-09-16.
What interventions are being tested in trial NCT04147897?
The interventions under investigation include: FOCUS (DEVICE).
Who is sponsoring clinical trial NCT04147897?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04147897's enrollment target sits among peer trials
299 371st of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI